BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30643567)

  • 1. Interview: developing therapies for lung cancer.
    Novello S
    Lung Cancer Manag; 2017 Jul; 6(1):25-27. PubMed ID: 30643567
    [No Abstract]   [Full Text] [Related]  

  • 2. What does the future hold for the Lung Cancer Ambition Alliance project: an interview with Giorgio Scagliotti.
    Scagliotti G
    Future Oncol; 2020 Mar; 16(7):221-223. PubMed ID: 32020812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From the History of the Croatian Dermatovenereological Society - The Croatian Medical Association and an Overview of Important Information Regarding the Journal Acta Dermatovenerologica Croatica.
    Dobrić I
    Acta Dermatovenerol Croat; 2018 Dec; 26(4):344-348. PubMed ID: 30665489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AURA3 trial: does Tagrisso (osimertinib) have the potential to become the new standard of care for second-line treatment of patients with
    Papadimitrakopoulou VA
    Lung Cancer Manag; 2016 Dec; 5(4):159-162. PubMed ID: 30643560
    [No Abstract]   [Full Text] [Related]  

  • 5. The development of pain medicine in Italy and the rest of Europe 40 years after the first International Association for the Study of Pain Congress.
    Varrassi G; Paladini A
    Pain Manag; 2017 Jan; 7(1):15-18. PubMed ID: 27640221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Servier in oncology: bringing innovation to patients.
    Bertrand CP
    Future Oncol; 2019 Jul; 15(19):2191-2197. PubMed ID: 31146594
    [No Abstract]   [Full Text] [Related]  

  • 7. Advances in immunotherapy for melanoma.
    Ascierto PA; Larkin J
    Melanoma Manag; 2014 Aug; 1(1):19-24. PubMed ID: 30190806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of multiple myeloma: the impact of ixazomib's approval in Canada.
    Reece DE
    Int J Hematol Oncol; 2016 Nov; 5(3):97-99. PubMed ID: 30302208
    [No Abstract]   [Full Text] [Related]  

  • 9. Exploring liver physiology, pathology, TGF-β, EMT, stemness and new developments in liver cancer.
    Fabregat I
    Hepat Oncol; 2017 Jan; 4(1):9-13. PubMed ID: 30191049
    [No Abstract]   [Full Text] [Related]  

  • 10. What could the future hold for treatment sequencing in cancer medicine? An interview with Angela Märten.
    Märten A; Jenkins R
    Future Oncol; 2019 Sep; 15(25):2891-2893. PubMed ID: 31424270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Professor Hassan K. Awwad; The Father of Radiation Oncology and Radiobiology in Egypt and the Arab World, His Good Deeds Last Forever and Inspire us for the Future.
    Zaghloul MS; El-Badawi SA; Abd Elbaky H
    J Egypt Natl Canc Inst; 2007 Mar; 19(1):1-2. PubMed ID: 18839029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An interview with Julie Vose: where is oncology heading?
    Vose JM; Westcott G
    Future Oncol; 2015; 11(20):2803-5. PubMed ID: 26358047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lessons in chromatin organization and gender equity in research: an interview with Susan Gasser.
    Gasser SM
    Epigenomics; 2022 Mar; 14(6):331-337. PubMed ID: 35259924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trisenox: a paradigm shift in APL therapy, an interview with Francesco Lo-Coco.
    Lo-Coco F
    Int J Hematol Oncol; 2016 Nov; 5(3):101-104. PubMed ID: 30302209
    [No Abstract]   [Full Text] [Related]  

  • 15. Utilizing biomarkers in colorectal cancer: an interview with Ajay Goel.
    Goel A
    Future Oncol; 2017 Dec; 13(28):2511-2514. PubMed ID: 29168653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An interview with Alfredo Falcone and Lisa Salvatore: RECOURSE and trifluridine/tipiracil in metastatic colorectal cancer.
    Falcone A; Salvatore L
    Future Oncol; 2016 Sep; 12(18):2065-9. PubMed ID: 27266889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A discussion of blood cancers and the MPN landmark survey.
    Harrison C
    Int J Hematol Oncol; 2017 Dec; 6(4):101-104. PubMed ID: 30302230
    [No Abstract]   [Full Text] [Related]  

  • 18. Interview: commercial translation of cell-based therapies and regenerative medicine: learning by experience. Interview by Emily Culme-Seymour.
    Haseltine WA
    Regen Med; 2011 Jul; 6(4):431-5. PubMed ID: 21749201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. My thoughts on teaching.
    Smith BJ
    J Vet Med Educ; 2009; 36(3):256-9. PubMed ID: 19861711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An interview with Giuseppe Argenziano: an insight into the field of dermoscopy.
    Argenziano G
    Melanoma Manag; 2017 Mar; 4(1):9-11. PubMed ID: 30190902
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.